Miraculins Inc. To Present Study Results At Major Gastroenterology Conference

WINNIPEG, MANITOBA -- (MARKET WIRE) -- September 20, 2006 -- Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company, dedicated to the discovery and validation of cancer biomarkers for use in developing diagnostic tools and therapeutic products, is pleased to announce that it will be presenting results from the recent verification study for its colorectal cancer diagnostic at the Annual American College of Gastroenterology Scientific Meeting being held in Las Vegas, Oct 20-25, 2006.